Biggest News Aggregation in the World
📰 Seed Financing News

Page 5 - Seed Financing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Seed Financing. Real-time updates on events, politics, business and more.

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development | Vaccines

Hits: 137 GAITHERSBURG, MD, USA and GUANGZHOU, China I April 21, 2021 I RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today execution of definitive agreements for a seed round financing of $10 million. RNAimmune is a spin-off entity from Sirnaomics, a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases. Smooth River and Hong Kon...
United States Hong Kong Hongrun Los Angeles Patrick Lu University Of California Rnaimmune Inc

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 04/20/2021 | 09:00am EDT Send by mail : Message : 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced therapies sector, today announces that it has co-led a $10 million Seed financing round in Code Biotherapeutics, Inc. (“Code Bio” or the ”Company”), a next generation gene therapy company pioneering the development of t...
United States Olivia Manser Amber Fennell Rob Lin Dima Kuzmin Brianp Mcveigh

4Bio Capital: 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics

4Bio Capital: 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON - 4BIO Capital ("4BIO" or "the Group"), an international venture capital firm focused solely on the advanced therapies sector, today announces that it has co-led a $10 million Seed financing round in Code Biotherapeutics, Inc. ("Code Bio" or the "Company"), a next generation gene therapy company pioneering the development of targeted non-viral gene therapies for rare and prevalen...
United States New Enterprise Olivia Manser Amber Fennell Rob Lin Dima Kuzmin

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cellino Closes $16M Seed Financing led by The Engine and Khosla Ventures to Automate and Scale Stem Cell Manufacture -

What You Should Know: – Cellino, a Cambridge, MA-based personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC. – The company’s platform solves a time-consuming, major bottleneck of developing drugs that rely on cell therapy, having to remove stem cells b...
United Kingdom Nabiha Saklayen Humboldt Fund Cellino Closes Seed Financing Khosla Ventures

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science